An EBV reactivation test is a panel of antibody tests against Epstein-Barr virus proteins: the viral capsid antigen (VCA), the early antigen (EA) and the nuclear antigen (EBNA). Laboratories read the pattern as a whole, which can point to past infection, a recent primary infection or signs consistent with reactivation (CDC). Research links reactivation markers to long COVID in groups. A result does not diagnose.
Key takeaways
- The panel measures antibodies to VCA (IgM and IgG), EA and EBNA, and the timing of each tells a different part of the story (CDC).
- Antibodies to both VCA and EBNA suggest past infection. Up to 20% of healthy people carry early antigen antibodies for years, and unusual patterns occur in up to 10% of patients (CDC).
- In one study, 20 of 30 people with long COVID symptoms and 2 of 20 controls had antibody titres consistent with EBV reactivation (Gold et al., 2021).
- In 280 adults after SARS-CoV-2 infection, antibody evidence of recent reactivation went with long COVID with fatigue (Peluso et al., 2023).
- No EBV result diagnoses long COVID, which has no approved laboratory test (CDC).
What does an EBV reactivation test measure?
After an Epstein-Barr virus infection, the immune system makes antibodies to several of the virus's proteins. Each antibody has its own timeline, which is what lets a laboratory read an antibody panel as a story (CDC).
| Marker | Timing | Reading |
|---|---|---|
| Anti-VCA IgM | Appears early in infection and disappears within four to six weeks | Points to a recent primary infection |
| Anti-VCA IgG | Appears in the acute phase, peaks at two to four weeks, then persists for life | Shows infection at some point |
| Anti-EA IgG | Appears in the acute phase and falls to undetectable levels after three to six months in many people | Can fit recent infection or reactivation; up to 20% of healthy people carry it for years |
| Anti-EBNA | Appears two to four months after symptoms begin and persists for life | With VCA IgG, suggests past infection |
A primary infection shows anti-VCA IgM without EBNA antibodies. Antibodies to both VCA and EBNA suggest an infection from several months to years earlier (CDC).
What does "reactivation" mean on a lab report?
After infection, the antibodies to VCA and EBNA stay for life (CDC). Research on reactivation looks for antibody signs that the virus has become active after a quiet period, such as a positive early antigen result or VCA IgM in someone with signs of past infection. The long COVID studies below used those markers.
The CDC adds two cautions. Up to 20% of healthy people carry early antigen antibodies for years, and unusual antibody patterns turn up in up to 10% of patients (CDC). A positive early antigen result on its own is limited evidence of reactivation, and a clinician reads it with the rest of the panel and your symptoms.
What does research link EBV reactivation to in long COVID?
Three studies stand out, and each describes groups:
- A 2021 study found antibody titres consistent with EBV reactivation, early antigen IgG or VCA IgM, in 20 of 30 people with long COVID symptoms and in 2 of 20 controls (Gold et al., 2021). The samples were small.
- A 2023 study of 280 adults after SARS-CoV-2 infection found that antibody evidence of recent reactivation went with long COVID with fatigue (Peluso et al., 2023).
- A 2023 Nature study found higher antibody responses to several Epstein-Barr virus antigens in people with long COVID than in people who recovered (Klein et al., 2023).
Reactivation is one of several explanations researchers study, alongside viral material that persists and wider immune differences. An association in a group does not show that reactivation causes symptoms in one person. The long COVID guide sets the lines of evidence side by side.
What can an EBV test not tell you?
An EBV antibody panel cannot diagnose long COVID. The CDC states that no approved laboratory test can determine whether symptoms are due to long COVID, and routine blood tests may be normal in people who have it (CDC). The panel cannot tell you whether reactivation caused your symptoms, and it cannot choose a treatment. Because healthy people can carry reactivation markers, a positive result needs a clinician who knows your history.
If you have a result, bring it to your doctor with your symptom timeline, including the date of any infection before you became ill. Our piece on post-viral fatigue covers the fatigue pattern the 2023 study tied to reactivation markers.
What else can be measured?
An EBV panel reads antibodies to one virus. A broad immune panel reads the body's wider response: T-cell markers such as PD-1, LAG-3 and Granzyme B, interferons such as IFN-γ and chemokines such as IP-10, each against a healthy reference. A retest shows which way each moves. It adds context and does not diagnose.
For someone living with long COVID who wants objective data, the Mune Mirror™* Baseline Study measures 50 people with long COVID and 300 healthy participants, starts on 15 October 2026, includes up to three at-home blood draws and returns each participant's own results. Sign-up is an application and does not guarantee a place. Read about the Baseline Study.
Where Mune Mirror™ fits
Mune Mirror™ measures more than 1,000 immune and inflammation proteins from an at-home sample, benchmarks each against a healthy reference and repeats the measurement over time. Unwellness testing is blood testing for people whose standard labs come back normal but who still feel unwell: the people medicine has no answers for yet. It measures highly selected immune and inflammatory proteins that routine panels do not, so persistent symptoms can be tracked and made visible against a healthy reference. Mune Mirror™ is investigational and for research and informational use. It does not diagnose, treat, cure or prevent any disease.
You can see what Mune Mirror™ measures. You bring the results to your own doctor.
Frequently asked questions
What does a positive EBV early antigen test mean?
Antibodies to the early antigen appear in the acute phase of infection and fall away over three to six months in many people, so a positive result can fit a recent infection or reactivation. The CDC notes that up to 20% of healthy people carry these antibodies for years, so the result needs reading with the rest of the panel and your symptoms.
What does VCA IgG positive and EBNA positive mean?
Antibodies to both the viral capsid antigen and the nuclear antigen suggest a past Epstein-Barr virus infection, from several months to years earlier, according to the CDC. These antibodies persist for life.
Can EBV reactivation cause long COVID?
No one has shown that. Studies link antibody signs of EBV reactivation to long COVID, and to fatigue in particular, at the group level. Reactivation is one of several explanations researchers study, and an association does not settle cause and direction.
Should I get tested for EBV reactivation?
Discuss it with your doctor, who can decide whether the result would change anything in your care. An EBV antibody panel needs clinical interpretation, and it does not diagnose long COVID or ME/CFS.
Sources
- CDC. Laboratory Testing for Epstein-Barr Virus (EBV).
- Gold JE, et al. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens, 2021.
- Peluso MJ, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. Journal of Clinical Investigation, 2023.
- Klein J, et al. Distinguishing features of long COVID identified through immune profiling. Nature, 2023.
- CDC. Long COVID Basics.
Mune Mirror™ is currently in development, and the performance characteristics of this test have not yet been established. It is investigational. It does not diagnose, detect, screen for, treat, cure or prevent any disease. Results are for research and informational purposes, to discuss with your own doctor.